Activated T cell exosomes promote tumor invasion via Fas signaling pathway

Journal of Immunology

Volumn 188, Issue 12, 2012, Pages 5954-5961

  Cai, Zhijian ^a   Yang, Fei ^a   Yu, Lei ^a   Yu, Zhou ^a   Jiang, Lingling ^a   Wang, Qingqing ^a   Yang, Yunshan ^b   Wang, Lie ^a   Cao, Xuetao ^a   Wang, Jianli ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CD8+ T LYMPHOCYTE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXOSOME; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUNG; LUNG CANCER; MELANOMA B16; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; EXOSOMES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; LYMPHOCYTE ACTIVATION; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR ESCAPE; UP-REGULATION;

EID: 84862620981     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103466     Document Type: Article

References (48)

1. Peter, M. E., and P. H. Krammer. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10: 26-35. (Pubitemid 36511830)
2. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81. (Pubitemid 36688041)
3. Schulze-Osthoff, K., D. Ferrari, M. Los, S. Wesselborg, and M. E. Peter. 1998. Apoptosis signaling by death receptors. Eur. J. Biochem. 254: 439-459. (Pubitemid 28308094)
4. Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355-365. (Pubitemid 27131377)
5. Li, Y., A. J. Raffo, L. Drew, Y. Mao, A. Tran, D. P. Petrylak, and R. L. Fine. 2003. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143. Cancer Res. 63: 1527-1533. (Pubitemid 36373639)
6. Peng, S. L., M. E. Robert, A. C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184: 1149-1154. (Pubitemid 26313571)
7. Rokhlin, O. W., R. A. Glover, and M. B. Cohen. 1998. Fas-mediated apoptosis in human prostatic carcinoma cell lines occurs via activation of caspase-8 and caspase-7. Cancer Res. 58: 5870-5875. (Pubitemid 29006431)
8. Chen, L., S. M. Park, A. V. Tumanov, A. Hau, K. Sawada, C. Feig, J. R. Turner, Y. X. Fu, I. L. Romero, E. Lengyel, and M. E. Peter. 2010. CD95 promotes tumour growth. Nature 465: 492-496.
9. Zhang, Y., Q. Liu, M. Zhang, Y. Yu, X. Liu, and X. Cao. 2009. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J. Immunol. 182: 3801-3808.
10. Li, H., X. Fan, C. Stoicov, J. H. Liu, S. Zubair, E. Tsai, R. Ste Marie, T. C. Wang, S. Lyle, E. Kurt-Jones, and J. Houghton. 2009. Human and mouse colon cancer utilizes CD95 signaling for local growth and metastatic spread to liver. Gastroenterology 137: 934-944, 944.e1-4.
11. Mitsiades, C. S., V. Poulaki, G. Fanourakis, E. Sozopoulos, D. McMillin, Z. Wen, G. Voutsinas, S. Tseleni-Balafouta, and N. Mitsiades. 2006. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin. Cancer Res. 12: 3705-3712. (Pubitemid 44000250)
12. Shinohara, H., H. Yagita, Y. Ikawa, and N. Oyaizu. 2000. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation. Cancer Res. 60: 1766-1772. (Pubitemid 30183454)
13. Barnhart, B. C., P. Legembre, E. Pietras, C. Bubici, G. Franzoso, and M. E. Peter. 2004. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 23: 3175-3185. (Pubitemid 39093611)
14. Nijkamp, M. W., F. J. Hoogwater, E. J. Steller, B. F. Westendorp, T. A. van der Meulen, M. W. Leenders, I. H. Borel Rinkes, and O. Kranenburg. 2010. CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. J. Hepatol. 53: 1069-1077.
15. Martínez-Lorenzo, M. J., A. Anel, S. Gamen, I. Monleón, P. Lasierra, L. Larrad, A. Piñeiro, M. A. Alava, and J. Naval. 1999. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J. Immunol. 163: 1274-1281. (Pubitemid 29352744)
16. Johnstone, R. M., M. Adam, J. R. Hammond, L. Orr, and C. Turbide. 1987. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262: 9412-9420.
17. Chaput, N., and C. Théry. 2011. Exosomes: immune properties and potential clinical implementations. Semin. Immunopathol. 33: 419-440.
18. Mincheva-Nilsson, L., and V. Baranov. 2010. The role of placental exosomes in reproduction. Am. J. Reprod. Immunol. 63: 520-533.
19. Xie, Y., H. Zhang, W. Li, Y. Deng, M. A. Munegowda, R. Chibbar, M. Qureshi, and J. Xiang. 2010. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. J. Immunol. 185: 5268-5278.
20. Fridman, R., M. Toth, D. Peña, and S. Mobashery. 1995. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55: 2548-2555.
21. van Deventer, H. W., Q. P. Wu, D. T. Bergstralh, B. K. Davis, B. P. O'Connor, J. P. Ting, and J. S. Serody. 2008. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am. J. Pathol. 173: 253-264.
22. Kleber, S., I. Sancho-Martinez, B. Wiestler, A. Beisel, C. Gieffers, O. Hill, M. Thiemann, W. Mueller, J. Sykora, A. Kuhn, et al. 2008. Yes and PI3K bind CD95 to signal invasion of glioblastoma. Cancer Cell 13: 235-248. (Pubitemid 351324880)
23. Chen, W., J. Wang, C. Shao, S. Liu, Y. Yu, Q. Wang, and X. Cao. 2006. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur. J. Immunol. 36: 1598-1607. (Pubitemid 43942147)
24. Dai, S., T. Wan, B. Wang, X. Zhou, F. Xiu, T. Chen, Y. Wu, and X. Cao. 2005. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin. Cancer Res. 11: 7554-7563. (Pubitemid 41507718)
25. Zhang, X., H. Huang, J. Yuan, D. Sun, W. S. Hou, J. Gordon, and J. Xiang. 2005. CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 175: 2931-2937. (Pubitemid 41170510)
26. Letellier, E., S. Kumar, I. Sancho-Martinez, S. Krauth, A. Funke-Kaiser, S. Laudenklos, K. Konecki, S. Klussmann, N. S. Corsini, S. Kleber, et al. 2010. CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity 32: 240-252.
27. Liu, L. P., H. F. Liang, X. P. Chen, W. G. Zhang, S. L. Yang, T. Xu, and L. Ren. 2010. The role of NF-kappaB in Hepatitis b virus X protein-mediated upregulation of VEGF and MMPs. Cancer Invest. 28: 443-451.
28. Sharp, D. A., D. A. Lawrence, and A. Ashkenazi. 2005. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 280: 19401-19409. (Pubitemid 41379648)
29. Rippo, M. R., S. Moretti, S. Vescovi, M. Tomasetti, S. Orecchia, G. Amici, A. Catalano, and A. Procopio. 2004. FLIP overexpression inhibits death receptorinduced apoptosis in malignant mesothelial cells. Oncogene 23: 7753-7760. (Pubitemid 39457025)
30. Chang, D. W., Z. Xing, Y. Pan, A. Algeciras-Schimnich, B. C. Barnhart, S. Yaish-Ohad, M. E. Peter, and X. Yang. 2002. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21: 3704-3714. (Pubitemid 34787044)
31. Golks, A., D. Brenner, C. Fritsch, P. H. Krammer, and I. N. Lavrik. 2005. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 280: 14507-14513. (Pubitemid 40562792)
32. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 10: 640-648. (Pubitemid 30354699)
33. Micheau, O., S. Lens, O. Gaide, K. Alevizopoulos, and J. Tschopp. 2001. NFkappaB signals induce the expression of c-FLIP. Mol. Cell. Biol. 21: 5299-5305. (Pubitemid 32702435)
34. Armstrong, A. C., D. Eaton, and J. C. Ewing. 2001. Science, medicine, and the future: Cellular immunotherapy for cancer. BMJ 323: 1289-1293. (Pubitemid 33135163)
35. Bronte, V., T. Kasic, G. Gri, K. Gallana, G. Borsellino, I. Marigo, L. Battistini, M. Iafrate, T. Prayer-Galetti, F. Pagano, and A. Viola. 2005. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med. 201: 1257-1268. (Pubitemid 40629069)
36. van Niel, G., and M. Heyman. 2002. The epithelial cell cytoskeleton and intracellular trafficking. II. Intestinal epithelial cell exosomes: perspectives on their structure and function. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G251-G255. (Pubitemid 34791289)
37. Kim, J., J. A. Pyun, S. Won Cho, K. Lee, and K. Kwack. 2011. Lymph node metastasis of gastric cancer is associated with the interaction between poly (ADP-ribose) polymerase 1 and matrix metallopeptidase 2. DNA Cell Biol. 30: 1011-1017.
38. Kim, H., J. Y. Song, J. Y. Cho, Y. S. Yoon, H. S. Han, H. S. Lee, H. S. Ryu, and G. Choe. 2010. Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis. J. Clin. Pathol. 63: 1048-1053.
39. Fu, L., C. Zhang, L. Y. Zhang, S. S. Dong, L. H. Lu, J. Chen, Y. Dai, Y. Li, K. L. Kong, D. L. Kwong, and X. Y. Guan. 2011. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut 60: 1635-1643.
40. Mathas, S., A. Lietz, I. Anagnostopoulos, F. Hummel, B. Wiesner, M. Janz, F. Jundt, B. Hirsch, K. Jöhrens-Leder, H. P. Vornlocher, et al. 2004. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. J. Exp. Med. 199: 1041-1052. (Pubitemid 38619901)
41. Kim, Y., N. Suh, M. Sporn, and J. C. Reed. 2002. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 277: 22320-22329. (Pubitemid 34967199)
42. Toivonen, H. T., A. Meinander, T. Asaoka, M. Westerlund, F. Pettersson, A. Mikhailov, J. E. Eriksson, and H. Saxén. 2011. Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95- mediated apoptosis. J. Biol. Chem. 286: 18375-18382.
43. Kaunisto, A., V. Kochin, T. Asaoka, A. Mikhailov, M. Poukkula, A. Meinander, and J. E. Eriksson. 2009. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ. 16: 1215-1226.
44. D'Souza, W. N., C. F. Chang, A. M. Fischer, M. Li, and S. M. Hedrick. 2008. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J. Immunol. 181: 7617-7629.
45. Subramanian, M., and C. Shaha. 2007. Up-regulation of Bcl-2 through ERK phosphorylation is associated with human macrophage survival in an estrogen microenvironment. J. Immunol. 179: 2330-2338.
46. Ungefroren, H., M. Voss, M. Jansen, C. Roeder, D. Henne-Bruns, B. Kremer, and H. Kalthoff. 1998. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 58: 1741-1749. (Pubitemid 28215103)
47. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268: 411-415.
48. Yanagisawa, J., M. Takahashi, H. Kanki, H. Yano-Yanagisawa, T. Tazunoki, E. Sawa, T. Nishitoba, M. Kamishohara, E. Kobayashi, S. Kataoka, and T. Sato. 1997. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J. Biol. Chem. 272: 8539-8545. (Pubitemid 27147818)